These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 6821613)
1. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Wilmshurst PT; Thompson DS; Jenkins BS; Coltart DJ; Webb-Peploe MM Br Heart J; 1983 Jan; 49(1):77-82. PubMed ID: 6821613 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy. Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Coltart DJ; Webb-Peploe MM Br Heart J; 1984 Jul; 52(1):38-48. PubMed ID: 6743422 [TBL] [Abstract][Full Text] [Related]
4. [Hemodynamic effects of various doses of a new inotropic: amrinoma]. Cárdenas M; Vidaurri A Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781 [TBL] [Abstract][Full Text] [Related]
5. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Gage J; Rutman H; Lucido D; LeJemtel TH Circulation; 1986 Aug; 74(2):367-73. PubMed ID: 3731427 [TBL] [Abstract][Full Text] [Related]
6. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study]. Veit S; Brückner JB; Vogt K; Wagner R; Hess W Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153 [TBL] [Abstract][Full Text] [Related]
7. Haemodynamic dose-response effects of intravenous amrinone in left ventricular failure complicating acute myocardial infarction. Verma SP; Silke B; Reynolds GW; Hafizullah M; Jackson NC; Taylor SH J Cardiovasc Pharmacol; 1985; 7(6):1101-6. PubMed ID: 2418295 [TBL] [Abstract][Full Text] [Related]
8. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog. Makela VH; Kapur PA Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021 [TBL] [Abstract][Full Text] [Related]
9. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related]
10. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle. Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180 [TBL] [Abstract][Full Text] [Related]
11. Effect of amrinone on right ventricular function: predominance of afterload reduction. Konstam MA; Cohen SR; Salem DN; Das D; Aronovitz MJ; Brockway BA Circulation; 1986 Aug; 74(2):359-66. PubMed ID: 3731426 [TBL] [Abstract][Full Text] [Related]
12. Clinical effects of intravenous amrinone in patients with congestive heart failure. Goldstein RA Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775 [TBL] [Abstract][Full Text] [Related]
13. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
14. Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function. Wilmshurst PT; Thompson DS; Juul SM; Dittrich HC; Dawson JR; Walker JM; Jenkins BS; Coltart DJ; Webb-Peploe MM Br Heart J; 1985 May; 53(5):493-506. PubMed ID: 3994862 [TBL] [Abstract][Full Text] [Related]
15. Inotropic and vasodilating properties of amrinone depend on the mode of administration. Hartog JM; Saxena PR; Verdouw PD Eur Heart J; 1986 Dec; 7(12):1067-76. PubMed ID: 3830202 [TBL] [Abstract][Full Text] [Related]
16. Dose-related cardiovascular effects of amrinone and epinephrine in reversing bupivacaine-induced cardiovascular depression. Igarashi T; Hirabayashi Y; Saitoh K; Fukuda H; Shimizu R; Mitsuhata H Acta Anaesthesiol Scand; 1998 Jul; 42(6):698-706. PubMed ID: 9689277 [TBL] [Abstract][Full Text] [Related]
18. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure. Hashimoto K; Yabuuchi Y; Yamashita S; Mori T Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties. Bottorff MB; Rutledge DR; Pieper JA Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583 [TBL] [Abstract][Full Text] [Related]
20. [Right ventricular hemodynamics and lung function following amrinone injection]. Klepzig M; Baur X; Hauser F; Mernitz G; Fruhmann G; Strauer BE Z Kardiol; 1984 Oct; 73(10):623-7. PubMed ID: 6516514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]